Cardiac consequences of hypertension in hemodialysis patients

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Hypertension is a major risk factor for cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients.
• Left ventricular hypertrophy (LVH) integrates long-term hypertension effects and predicts adverse cardiovascular outcomes in ESRD.
• Patients with hypertensive renal disease face higher heart failure risks compared to other diagnoses.

Purpose of the Study:

• To review the significant impact of hypertension on cardiovascular complications in ESRD.
• To highlight LVH as a critical predictor of mortality in ESRD patients.
• To discuss the association between hypertension, LVH, and cardiovascular events like heart failure and arrhythmias.

Main Methods:

• Literature review of studies examining hypertension, LVH, and cardiovascular outcomes in ESRD.
• Analysis of cross-sectional and prospective data linking hypertension history to ischemic heart disease.
• Examination of prevalence and impact of arrhythmias in dialysis patients.

Main Results:

• Hypertension in ESRD is linked to left ventricular hypertrophy (LVH), cardiac failure, coronary artery disease (CAD), and arrhythmia.
• LVH is the strongest predictor of adverse cardiovascular outcomes in ESRD.
• Long-standing hypertension is associated with ischemic heart disease, and arrhythmias are highly prevalent in dialysis patients, contributing to mortality.

Conclusions:

• Interventions targeting both hypertension and LVH are recommended to reduce high cardiovascular mortality in ESRD.
• Despite limited randomized controlled trial evidence, managing hypertension and LVH is a reasonable strategy.
• Addressing these factors is critical for improving cardiovascular health in the ESRD population.